摘要
癌症恶病质是一种使人衰弱的副肿瘤综合征。它的特点是骨骼肌消耗和体重下降。它影响了50-80%的癌症患者,并且直接占因心肺衰竭癌症死亡的25%。肌肉无力,这种综合征的标志之一,已被假定为是由于肌肉分解,功能障碍和减少的修复能力以及当前限制的有效治疗策略导致的。由于宿主肿瘤的作用,如白细胞介素(IL)6和肿瘤坏死因子(TNF)-α导致了过度的炎症细胞因子的水平被假设以驱动这一病理过程,而使这些细胞因子在癌性恶病质中产生骨骼肌功能障碍的具体机制尚不明确。内质网应激(ER)和钙信号相关的中断在骨骼肌和功能的细胞因子介导的中断中十分重要。中断的内质网应激过程如未折叠蛋白反应(UPR),钙稳态以及改变肌肉蛋白质的合成已在临床和实验性恶病质等炎症驱动肌肉疾病如肌炎中报道,可能与这之间增加的IL-6和TNF-α以及骨骼肌细胞中的内质网应激有关系。在骨骼肌细胞中,由于增加的细胞因子的上调的内质网应力的概念是新的并潜在的与我们对癌症恶病质的理解十分相关,本文旨在探讨炎性细胞因子与肌肉分解和ER应激介导之间的潜在关系,在癌症恶病质的内容中,去探讨其分子信号通路的基础病理学。
关键词: 骨骼肌;癌性恶病质;内质网;蛋白质转换;钙;细胞因子。
Current Drug Targets
Title:Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting
Volume: 17 Issue: 10
Author(s): Stephanie T. Isaac, Timothy C. Tan, Patsie Polly
Affiliation:
关键词: 骨骼肌;癌性恶病质;内质网;蛋白质转换;钙;细胞因子。
摘要: Cancer cachexia is a debilitating paraneoplastic wasting syndrome characterized by skeletal muscle depletion and unintentional weight loss. It affects up to 50-80% of patients with cancer and directly accounts for one-quarter of cancer-related deaths due to cardio-respiratory failure. Muscle weakness, one of the hallmarks of this syndrome, has been postulated to be due to a combination of muscle breakdown, dysfunction and decrease in the ability to repair, with effective treatment strategies presently limited. Excessive inflammatory cytokine levels due to the host-tumor interaction, such as Interleukin (IL)-6 and Tumor Necrosis Factor (TNF)-α, are hypothesised to drive this pathological process but the specific mechanisms by which these cytokines produce skeletal muscle dysfunction in cancer cachexia remain undefined. Endoplasmic Reticulum (ER) stress and the associated disruptions in calcium signaling have been implicated in cytokine-mediated disruptions in skeletal muscle and function. Disrupted ER stress-related processes such as the Unfolded Protein Response (UPR), calcium homeostasis and altered muscle protein synthesis have been reported in clinical and experimental cachexia and other inflammation-driven muscle diseases such as myositis, potentially suggesting a link between increased IL-6 and TNF-α and ER stress in skeletal muscle cells. As the concept of upregulated ER stress in skeletal muscle cells due to elevated cytokines is novel and potentially very relevant to our understanding of cancer cachexia, this review aims to examine the potential relationship between inflammatory cytokine mediated muscle breakdown and ER stress, in the context of cancer cachexia, and to discuss the molecular signaling pathways underpinning this pathology.
Export Options
About this article
Cite this article as:
Stephanie T. Isaac, Timothy C. Tan, Patsie Polly , Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting, Current Drug Targets 2016; 17 (10) . https://dx.doi.org/10.2174/1389450116666150416115721
DOI https://dx.doi.org/10.2174/1389450116666150416115721 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in the Management of Malignant Hemopathies: The Role of Statins
Recent Patents on DNA & Gene Sequences Advances in Drug Therapy for Systemic Lupus Erythematosus
Current Medicinal Chemistry HDL Therapy: Two Kinds of Right?
Current Pharmaceutical Design Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPARα, PPARγ, and PPARδ
Current Diabetes Reviews Endothelins Role in the Control of the Acute Phase of Trypanosoma cruzi Infection
Mini-Reviews in Medicinal Chemistry Applications of Animal Models of Infectious Arthritis in Drug Discovery:A focus on Alphaviral Disease
Current Drug Targets Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design Review of Pediatric Osteoarticular Infections
Reviews on Recent Clinical Trials Immune Monitoring to Predict the Development of Infections After Immunosuppression for Solid Organ Transplantation and Autoimmune Diseases
Current Drug Safety Regeneration of Mammalian Skeletal Muscle: Basic Mechanisms and Clinical Implications
Current Pharmaceutical Design Targeting Serine Proteases in Asthma
Current Topics in Medicinal Chemistry Biologics in Systemic Sclerosis
Current Pharmaceutical Biotechnology A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
Current Pharmaceutical Design Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Microchimerism in Health and Disease
Current Molecular Medicine Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development
Current Organic Synthesis Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy
Recent Patents on Anti-Infective Drug Discovery